News

New drugs, strategies advance rheumatoid arthritis treatment


 

New biologics and more aggressive intervention strategies have advanced rheumatoid arthritis treatment over the last decade, Dr. Iain McInnes explains, but remission remains too infrequent. New drugs under development in the coming years offer promise for the future. For more on rheumatoid arthritis advances, visit http://www.rheumatologynews.com.

Recommended Reading

Methotrexate assay useful in severe pediatric dermatitis, psoriasis
MDedge Rheumatology
FDA: Acetaminophen linked to rare, serious skin reactions, fatalities
MDedge Rheumatology
Suboptimal, dissatisfying treatment affects many psoriasis patients
MDedge Rheumatology
Five pearls guide pediatric psoriasis systemic therapy
MDedge Rheumatology
Psoriasis linked to increased heart failure risk
MDedge Rheumatology
Ustekinumab approved for psoriatic arthritis
MDedge Rheumatology
Palmar-plantar psoriasis? Anti-TNF therapy may be culprit
MDedge Rheumatology
Psoriasis linked to nonalcoholic fatty liver disease
MDedge Rheumatology
Secukinumab soars in phase III psoriasis studies
MDedge Rheumatology
Fixed maintenance secukinumab beats as-needed dosing
MDedge Rheumatology